PhRMA Does About-Face On Drug-Price Transparency As Pressure Mounts

The brand-drug lobby doggedly mounted legal challenges to landmark drug price transparency laws in California and Nevada over the past two years, but the Pharmaceutical Research and Manufacturers of America recently changed its tune and supports a transparency bill in Maryland this legislative session. Grassroots advocates say PhRMA flip-flopped to try to get state lawmakers to support the transparency measure instead of establishing a much more aggressive payment-setting commission for expensive drugs. Jane Horvath, an independent health care policy consultant...